# Real-world Study on the Efficacy, Safety, and Prognostic Factors of Immune Checkpoint Inhibitors Combined With Radiotherapy in Patients With Malignant Tumors: A Prospective Non-interventional Clinical Study

> **NCT07665736** · — · NOT_YET_RECRUITING · sponsor: **Sichuan University** · enrollment: 200 (estimated)

## Conditions studied

- Radiotherapy
- Immune Checkpoint Inhibitors (ICIs)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07665736
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2029-06-15
- **Final completion:** 2029-06-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665736, "Real-world Study on the Efficacy, Safety, and Prognostic Factors of Immune Checkpoint Inhibitors Combined With Radiotherapy in Patients With Malignant Tumors: A Prospective Non-interventional Clinical Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*